Litigation Details for In Re Copaxone 40 MG Consolidated Cases (D. Del. 2014)
✉ Email this page to a colleague
In Re Copaxone 40 MG Consolidated Cases (D. Del. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-09-10 |
| Court | District Court, D. Delaware | Date Terminated | 2017-01-31 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Defendant | Referred To | |
| Parties | TEVA PHARMACEUTICAL INDUSTRIES LTD | ||
| Patents | 6,054,430; 6,342,476; 6,362,161; 6,468,967; 6,483,009; 6,852,689; 7,199,098; 7,511,014; 8,232,250; 8,399,413; 8,552,025; 8,642,025; 8,969,302; 9,155,776; 9,533,022; 9,555,023 | ||
| Attorneys | Brian M. Kramer | ||
| Firms | Duane Morris LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In Re Copaxone 40 MG Consolidated Cases
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in In Re Copaxone 40 MG Consolidated Cases
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for In Re Copaxone 40 MG Consolidated Cases (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-11-03 | 114 | Stipulation | invalidity of U.S. Patent Nos. 8,232,250 (“the ’250 patent”), 8,399,413 (“the ’413 patent”), and 8,969,302…8,969,302 (“the ’302 patent) (collectively, the “patents-in-suit”), which, like the ’776 patent, are …’776 patent shares a common inventor and specification with the patents-in-suit and each patent is generally… Court: WHEREAS, U.S. Patent No. 9,155,776 (“the ’776 patent”) issued on October 13, 2015 and…that the patents involve similar subject matter, amending the pleadings to include the ’776 patent would | External link to document |
| 2015-11-10 | 116 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,232,250; 8,399,413; 8,969,302…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware | External link to document |
| 2015-11-20 | 127 | Notice of Service | Defendants' Proposed Claim Constructions for U.S. Patent No. 9,155,776 filed by Mylan Inc., Mylan Pharmaceuticals…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware | External link to document |
| 2015-12-04 | 130 | Notice of Service | Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 B2 filed by Momenta Pharmaceuticals Inc.…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware | External link to document |
| 2015-12-18 | 139 | Claim Construction Opening Brief | CONSTRUCTION OPENING BRIEF Regarding U.S. Patent No. 9,155,776 filed by Momenta Pharmaceuticals Inc., Sandoz…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
